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Ultrasound on the Frontlines of COVID-19: Report from an International
Webinar
Introduction

The COVID-19 pandemic has spread to 185 countries with over 2.1 million confirmed

cases and 145,000 deaths, as per the Johns Hopkins University COVID-19 dashboard provided at
https://coronavirus.jhu.edu/map.html. Imaging modalities such as chest radiography, thoracic

and cardiovascular ultrasound, and computed tomography have roles in the diagnosis, prognosis,
monitoring, and therapy of COVID-19. However, the potential benefits of imaging need to be
balanced against resource utilization and infectious risk.
Point-of-care ultrasound (POCUS) represents an attractive imaging modality in COVID-

19 as it involves portable technology without radiation. POCUS is performed by a clinician at the
patient’s bedside, reducing exposure of additional personnel and avoiding virulent particle
transmission during transport to other areas.
On March 18th, 2020, the American College of Emergency Physicians (ACEP) hosted a

virtual town hall meeting to discuss the use of POCUS in COVID-19 patients. The panel of nine
emergency physicians included those on the forefront of outbreaks in Spain, Italy, and
Washington State as well as POCUS leaders who are heavily involved in developing processes
for their institutions.
We seek to summarize available literature on imaging in COVID-19 and provide

informally-derived recommendations of the panel on POCUS use in COVID-19. The webinar
may be accessed at https://www.acep.org/how-we-serve/sections/emergency-ultrasound/.
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Current imaging approaches in COVID-19

Computed Tomography (CT)
CT represents the most sensitive imaging modality for COVID-19 involvement of the

lungs. Ground glass opacities, patchy bilateral consolidations, or peripheral interstitial changes

were found in 97% of confirmed COVID-19 patients, and CT was potentially more reliable than
RT-PCR swab testing.1 Four stages of CT findings demonstrated progression from ground-glass

opacities to consolidations that gradually resolved. Peak findings occurred 10 days after
symptom onset.2
CT may be sensitive for evidence of lung involvement from COVID-19, but resource

utilization and infection control risks are significant issues. Airborne transmission and ventilation
of CT scanner rooms present concerns, and cleaning after exposure from a COVID-19 patient
could render the CT unusable for several hours. Based on the uncertain impact of CT imaging on
patient care as well as infection control issues, the American College of Radiology (ACR) has
stated “CT should not be used to screen for or as a first-line test to diagnose COVID-19”.3

Chest Radiography (CXR)
CXR is widely available, portable and likely to be utilized in the initial and ongoing

evaluation of COVID-19 patients. Comparisons between CXR and CT are not extensive at this

time, but suggest that CXR is often normal when the CT is abnormal.4 CXR still carries risk of
exposure to personnel and contamination of machines. One approach to mitigate infectious risk
involves obtaining a single view CXR outside the patient’s room through a glass window. The
ACR guidelines on radiography in COVID-19 suggest portable CXR when it is considered
“medically necessary”.3 Further data is needed on the sensitivity, specificity, and diagnostic
impact of CXR on suspected and diagnosed COVID-19 patients.

Ultrasonography
Ultrasound of the lung utilizes artifacts and findings at the lung periphery, and early

reports show that abnormal findings are common in COVID-19 patients. A series of twenty
patients with COVID-19 described thickening and irregularity of the pleural line, a variety of B-
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line patterns and subpleural consolidations. Pleural effusions were rare.6 A recent comparison of
imaging modalities in intensive care patients suffering from acute respiratory failure
demonstrated high agreement between lung ultrasound and CT. Ultrasound out-performed chest
radiography particularly when assessing interstitial pathologies, as well as ground glass opacities
and consolidations.6 Since the sensitivity of CT is high in COVID-19 patients and progression of
disease is apparent, it is likely that lung ultrasound closely mirrors the longitudinal changes
found through CT. High sensitivity and specificity of lung ultrasound seen in acute respiratory
distress syndrome (ARDS) as well as in H1N1 influenza suggest that similar test characteristics
exist for lung ultrasound in COVID-19.7,8 Lung ultrasound also shows prognostic capabilities in
ARDS before hypoxemia becomes evident.8 While reports on lung ultrasound in COVID-19 are

preliminary, they suggest ultrasound findings are likely more common than findings on plain
chest radiography. POCUS may also identify and exclude other pulmonary causes of dyspnea as

well as cardiac abnormalities. Future research should further specify test characteristics of
ultrasound in COVID-19, as well as assessments of harm to ultrasound operators who risk
increased contact with infected patients.

Expert Observations from the Town Hall:

1. Ultrasound in the diagnosis and monitoring of COVID-19

In the initial evaluation of a non-critical patient with suspected COVID-19,
panelists posited that either a completely normal or a completely abnormal lung
ultrasound may be helpful. A completely normal examination likely excludes a patient
requiring further imaging at that time. Characteristically abnormal findings in a person
under investigation for COVID-19 may identify patients requiring further evaluation or
closer observation before RT-PCR results return. It is unclear whether B-line or
consolidation thresholds exist that predict significant clinical deterioration in wellappearing patients who display lung findings. Observations that ultrasound findings may
precede clinical symptoms suggests that ultrasound may identify more severe illness prior
to the development of severe symptoms.

This article is protected by copyright. All rights reserved

Accepted Article

While lung ultrasound may be of little utility in patients who are critically ill from
COVID-19, it may help exclude other pulmonary diseases (including pleural effusion or
pneumothorax).6 Incorporation of cardiac ultrasound could also identify cardiac
complications from COVID-19 and it is recommended that a focused cardiac ultrasound
be incorporated into the evaluation of symptomatic COVID-19 patients. Early reports
suggest there may be direct cardiac ramifications of COVID-19 including gross LV
dysfunction, and potential RV dilation.9,10 Additional to lung ultrasound, cardiac views
including the inferior vena cava can help identify or exclude cardiac dysfunction.
Ultrasound may also benefit critically ill patients requiring emergent peripheral or
central venous access. Due to respiratory distress, some patients are unable to lie flat,
making central venous access difficult. Ultrasound also assists in diagnosis of venous
thromboembolism. Table 1 summarizes the main ultrasound applications used and their
associated findings in COVID-19 patients.
Future systematic research is needed to clarify the above associations between
ultrasound findings and presence of illness, prognostication of illness severity, and
ultimate patient outcomes. Panelists emphasized that while ultrasound findings are often
characteristic of COVID-19 and may be more prominent in more severe disease,
disposition decisions such as admission and level of care would likely be made
predominantly on clinical appearance.

2. Ultrasound equipment

Newer pocket-carried ultrasound devices using tablet and smartphone technology
may be easier to maneuver, protect, and clean after use on COVID-19 patients. It is
feasible for the screen to be completely encased in a covering such as a Ziploc bag, and
for transducers to be fully enclosed using sheaths. They may be particularly useful in
situations where separate care or triage areas for cohorted COVID-19 patients are
established outside the main areas where traditional machines reside. Additionally,
teleguidance software built into these devices may be useful in providing remote
instruction or evaluation of patients who are physically located away from typical
treatment areas. Telemedicine and cloud-based image sharing may improve the capacity
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for care outside the hospital setting, and serial lung exams may provide objective data in
remote or virtual clinical decision-making.

3. Infection control issues

Aggressive infection control was emphasized by all panelists, as a recent report
suggested that the SARS-CoV-2 virus could survive for days on some surfaces.11 Routine
cleaning and disinfection procedures recommended by the Centers for Disease Control
are particularly important when procedures with high risk of aerosolization are
performed. Prior to entering the room, all unnecessary equipment including extra probes
should be removed from the machine to minimize surface exposures. If available,
transparent covers for machines and probes can be considered. If resources allow,
equipment that is dedicated for use in patients with suspected or confirmed COVID-19
may be helpful. The Environmental Protection Agency maintains a list of SARS-CoV-2
approved disinfectants (https://www.epa.gov/pesticide-registration/list-n-disinfectantsuse-against-sars-cov-2).

Conclusion

Ultrasound as a diagnostic test presents distinct advantages for imaging in COVID-19. It

is a mobile technology that can be used in diverse environments, including in triage tents or

makeshift hospitals that are now established for COVID-19 evaluation at many centers. POCUS
in particular, where the clinician both performs and interprets the images immediately at the
bedside, can minimize involvement of additional personnel in an infectious situation and provide
immediate diagnostic information. However, care must be taken to avoid increased transmission
of disease.
Incorporating ultrasound into the evaluation of COVID-19 patients will depend upon

available resources, expertise of personnel, and logistic configurations unique to each situation.
Further research and data are needed to determine the role of ultrasound as a screening tool for
establishing both admission thresholds and level of care, its use in prognostication and
monitoring of inpatients, as well as novel uses like home telemonitoring in discharged patients.
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Ultrasound appears promising as a first-line and comprehensive diagnostic imaging modality in
suspected or diagnosed COVID-19.

The authors wish to acknowledge ACEP in arranging this webinar, as well as the Society of
American Emergency Medicine, the American Academy of Emergency Medicine, and the
Society of Clinical Ultrasound Fellowships for co-hosting this panel.
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Table 1: Point-of-Care Ultrasound Applications and Findings in COVID-19 patients

Lung Ultrasound
o Panelists used 6-12 zones, or less



Thickened, irregular pleural line



B-lines with prominence in different
locations (“patchy” appearance). B-lines are
ring down artifacts from interstitial fluid
characteristic of pneumonitis.



Subpleural consolidations



Larger consolidations

o Parasternal long and short axis



Pericardial effusion

o Apical 4-chamber view



Depressed ejection fracture or gross LV

Cardiac Ultrasound

dysfunction

o Subxiphoid view



RV enlargement & evidence of strain

o Subxiphoid long axis (Inferior Vena



Hypo- or hypervolemia



Deep venous thrombosis



Guided peripheral or central access



Guided arterial lines

Cava) view

Vascular

NB: Panelists noted that there may be significant difficulties scanning all lung or cardiac views
due to patient positioning or comfort, and levels of distress.
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